Greenlight Biosciences Holdings Analysis
| GRNADelisted Stock | USD 0.30 0.00 0.00% |
Greenlight Biosciences Holdings is overvalued with Real Value of 0.23 and Hype Value of 0.3. The main objective of Greenlight Biosciences delisted stock analysis is to determine its intrinsic value, which is an estimate of what Greenlight Biosciences Holdings is worth, separate from its market price. There are two main types of Greenlight Biosciences' stock analysis: fundamental analysis and technical analysis.
The Greenlight Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Greenlight Biosciences' ongoing operational relationships across important fundamental and technical indicators.
Greenlight |
Greenlight Stock Analysis Notes
About 43.0% of the company shares are held by company insiders. The book value of Greenlight Biosciences was currently reported as 0.14. The company recorded a loss per share of 1.12. Greenlight Biosciences had not issued any dividends in recent years. GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid products for human health and agriculture applications. The company was founded in 2008 and is headquartered in Medford, Massachusetts. Greenlight Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To learn more about Greenlight Biosciences Holdings call the company at 617 616 8188 or check out https://greenlightbiosciences.com.Greenlight Biosciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Greenlight Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Greenlight Biosciences Holdings or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Greenlight Biosciences is not yet fully synchronised with the market data | |
| Greenlight Biosciences has some characteristics of a very speculative penny stock | |
| Greenlight Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.38 M. Net Loss for the year was (167.06 M) with loss before overhead, payroll, taxes, and interest of (87.22 M). | |
| Greenlight Biosciences Holdings currently holds about 44.13 M in cash with (136.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 43.0% of the company shares are held by company insiders |
Greenlight Biosciences Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Greenlight Biosciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of August 2023 Upcoming Quarterly Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View |
Greenlight Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 45.43 M.Greenlight Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Greenlight Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Greenlight Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Greenlight Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Greenlight Biosciences Outstanding Bonds
Greenlight Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Greenlight Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Greenlight bonds can be classified according to their maturity, which is the date when Greenlight Biosciences Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Greenlight Biosciences Predictive Daily Indicators
Greenlight Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Greenlight Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Greenlight Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Greenlight Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Greenlight shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Greenlight Biosciences. By using and applying Greenlight Stock analysis, traders can create a robust methodology for identifying Greenlight entry and exit points for their positions.
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid products for human health and agriculture applications. The company was founded in 2008 and is headquartered in Medford, Massachusetts. Greenlight Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Greenlight Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Greenlight Stock
If you are still planning to invest in Greenlight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenlight Biosciences' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |